# Paolo Gionchetti

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paolo-gionchetti/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,273 |
| Field | Inflammatory Bowel Disease |
| h-index | 73 |
| i10-index | 222 |
| Last Known Institution | IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola |
| OpenAlex ID | https://openalex.org/A5080965370 |
| ORCID iD | https://orcid.org/0000-0001-9479-5307 |
| Works | 493 |

## Researcher papers

- [Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders](https://scholariq.org/papers/third-european-evidence-based-consensus-on-diagnosis-and-management-of/)
- [ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-medical-treatment/)
- [ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-surgical-treatment/)
- [ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-ulcerative-colitis-medical-treatment/)
- [The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations](https://scholariq.org/papers/the-second-european-evidence-based-consensus-on-the-diagnosis-and-management-of/)
- [ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-ulcerative-colitis-surgical-treatment/)
- [Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease](https://scholariq.org/papers/advanced-age-is-an-independent-risk-factor-for-severe-infections-and-mortality/)
- [European evidence based consensus on surgery for ulcerative colitis](https://scholariq.org/papers/european-evidence-based-consensus-on-surgery-for-ulcerative-colitis/)
- [Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection](https://scholariq.org/papers/infliximab-reduces-endoscopic-but-not-clinical-recurrence-of-crohn-s-disease/)
- [A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease](https://scholariq.org/papers/a-phase-2-study-of-tofacitinib-an-oral-janus-kinase-inhibitor-in-patients-with/)
- [The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease☆](https://scholariq.org/papers/the-italian-society-of-gastroenterology-sige-and-the-italian-group-for-the-study/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Celiac Disease Research and Management](https://scholariq.org/topics/celiac-disease-research-and-management/)
- [Probiotics and Fermented Foods](https://scholariq.org/topics/probiotics-and-fermented-foods/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)

## Researcher university

- [IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola](https://scholariq.org/institutions/irccs-azienda-ospedliero-universitaria-di-bologna-policlinico-di-sant-orsola/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.